Restore Health Overview

  • Founded
  • 2013

Founded
  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • M&A

Restore Health General Information

Description

Provider of a health program intended to focus on individuals learning and how to make small lifestyle adjustments. The company has a twelve-month program that targets 30% of employees who compromise 70% of annual health care spend - those with Metabolic Syndrome and other core medical conditions, enabling employees to match with a personalized program designed to change unhealthy lifestyle habits.

Contact Information

Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Formerly VC-backed
Primary Industry
Educational and Training Services (B2C)
Other Industries
Application Software
Other Healthcare Services
Parent Company
Primary Office
  • 501 Boylston Street
  • 10th Floor
  • Boston, MA 02116
  • United States
+1 (855) 000-0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Restore Health Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Merger/Acquisition 01-Oct-2016 00.000 Completed Generating Revenue
4. Debt - General 31-Dec-2015 00000 00.000 Completed Startup
3. Debt - General 00.00 Completed Startup
2. Accelerator/Incubator $1.5M Completed Startup
1. Seed Round 20-Dec-2013 $1.5M $1.5M 00.000 Completed Startup
To view Restore Health’s complete valuation and funding history, request access »

Restore Health Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Seed 0,000,000 00.000000 00.00 00.00 00 00.00 00.000
To view Restore Health’s complete cap table history, request access »

Restore Health Patents

Restore Health Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-11000402-B2 Treatment for vesicovaginal fistula Active 19-Mar-2015 0000000000 00
US-20170360594-A1 Treatment for vesicovaginal fistula Active 19-Mar-2015 0000000000 00

Restore Health Former Investors (11)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
ACME Capital Venture Capital Minority 000 0000 000000 0
Adam Archer Angel (individual) Minority 000 0000 000000 0
Amar Chokhawala Angel (individual) Minority 000 0000 000000 0
Harrison Metal Capital Venture Capital Minority 000 0000 000000 0
Joshua Hug Angel (individual) Minority 000 0000 000000 0
You’re viewing 5 of 11 investors. Get the full list »